Thursday, June 6, 2013    

Open Forum: VC Roundtable 2013


Andrew Chung, Partner, Khosla Ventures
Jeff Clavier, Founder and Managing Partner, SoftTech VC
John Lilly, Partner, Greylock
Jonathan MacQuitty, Partner, Abingworth Life Science
Peter Sonsini, General Partner, NEA

Steve Bengston, Managing Director, Emerging Company Services, PwC

  2012 ended up being two years: before Facebook IPO and after. All the enthusiasm, hype, and expectations for the Facebook IPO were shattered even though it ended up being one of the biggest venture backed IPO's ever. The fallout was so extreme that 2013 is now being billed as the Star Trek year: the Enterprise is back. Is this just the venture spin machine working its magic or will we see a major shift from consumer to enterprise investment? Even with all the well-publicized problems in cleantech, biotech, and medical devices, VCs invested $26B and raised $21B in 2012. What can we expect to see in 2013? What has changed in fundraising? Is there a Series A crunch? What are the key metrics for losing a round? Join this discussion with four outspoken leading investors, as they opine on these key questions and more.

Corporate passes will be accepted for this event. We ask that if you register using corporate passes, please do so 72 business hours in advance. We thank you for your cooperation!

Sponsored by Microsoft, Womble Carlyle  

1065 La Avenida Street
Building 1
Mountain View, CA 94043


            Top            Privacy Policy     Site Credits © 2001-2010 Churchill Club 3150 Almaden Expressway, Suite 214, San Jose, CA 95118
Email: info@churchillclub.org